Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity. Winther JB, Holst JJ. Diabetes Obes Metab 2024 Jun 9. doi: 10.1111/dom.15693.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Winther JB, Holst JJ. Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity. Diabetes Obes Metab 2024 Jun 9. doi: 10.1111/dom.15693.
PMID: 38853300